Our outcomes provide new insights into the mechanism of DNA damage response in radioresistance, which suggest that inhibition of SALL4 have the potential to reverse the intrinsic and acquired radioresistance via inhibiting ATM/Chk2/p53 pathway in NPC patients. This evidence concerns the gene CHEK2 and nasopharyngeal carcinoma.